Richard Malamut
CIK 1772168 · EVP and Chief Medical Officer · last filed 2026-04-06
Richard Malamut is an EVP and Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing shows the insider sold $12.3K of PTHS on Apr 6, 2026. Across all open-market trades the lifetime net is −$2.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.65M
4
14
-$2.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | 28,742 | $27.50 | $790.4K | -$12.3K | 3 | 2026-04-06 |
| Pelthos Therapeutics Inc. (CHRO) Delisted | Director | 91,565 | $13.50 | $1.24M | $9.8K | 3 | 2024-11-15 |
| COLL | EVP and Chief Medical Officer | 136,564 | $34.64 | $4.73M | $0 | 7 | 2022-02-14 |
| ESPR | EVP and Chief Medical Officer | 42,500 | $3.15 | $133.9K | $0 | 1 | 2019-04-02 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-06 | PTHS | Sell (S) | −590 | -$12.3K | EDGAR |
| 2026-04-01 | PTHS | Grant (A) | +28,012 | $0 | EDGAR |
| 2025-07-07 | PTHS | Grant (A) | — | $0 | EDGAR |
| 2024-11-15 | Pelthos Therapeutics Inc. (CHRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-09-16 | Pelthos Therapeutics Inc. (CHRO) Delisted | Buy (P) | +10,400 | $9.8K | EDGAR |
| 2024-06-18 | Pelthos Therapeutics Inc. (CHRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-14 | COLL | Mixed | +36,706 | -$111.1K | EDGAR |
| 2021-04-05 | COLL | Tax (F) | −3,119 | -$72.9K | EDGAR |
| 2021-02-12 | COLL | Tax (F) | −2,300 | -$59.7K | EDGAR |
| 2021-01-22 | COLL | Grant (A) | +39,147 | $0 | EDGAR |